论文部分内容阅读
近年来，我们应用第二信使ｃＡＭＰ制剂美乐心注射液配合治疗哮喘持续状态８例，收到了良好的疗效。现报告如下。 临床资料：本组８例中，男２例，女６例；年龄３５～７２岁。其中合并缺血性心脏病２例。哮喘病史１～２５年。发病时间 ２～７天。 ＰａＯ２ ７． ７～９． ３ｋ
In recent years, we use the second messenger cAMP preparation Meilexin injection with the treatment of asthma in 8 cases, received a good effect. The report is as follows. Clinical data: The group of 8 patients, 2 males and 6 females; aged 35 to 72 years. Including ischemic heart disease in 2 cases. A history of asthma 1 to 25 years. Incidence of 2 to 7 days. PaO2 7. 7 ~ 9. 3k